Abstract
Flt3-ligand in combination with CD40-ligand gene transfer following radiation-incudible HSV-TK gene therapy improves survival in mice with diffuse hepatocellular carcinoma: Y Kawashita, Nj Deb, Mk Garg, Z Fan, Aa Alfieri, Sj Shah, Pk Chakravarty, Department of Radiation Oncology, Albert einstein college of medicine, Bronx, NY; N Roy-Chowdhury, Department of Medicine, Albert einstein college of medicine, Bronx, NY; B Vikram, Department
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
